european union

European General Court dismisses Lundbeck’s appeal against the Commission’s fine for delaying market entry of generic medicines

(The Italian version is also published on Diritto24 – Il Sole 24 Ore)

By decision of 8 September 2016 in T-472/13, the European General Court (“GC”) dismissed Lundbeck’s appeal against the European Commission (“EC”)’s decision to fine it – and a number of generic companies – for delaying market entry […]

By |13 09 2016|Uncategorized|0 Comments|

The Skype trademark cannot be registered in the EU due to a likelihood of confusion with the SKY trademark

By three decisions of 5 May 2015 in cases T-423/12, T-183/13 and T-184/13, the General Court of the European Union (“GC”), stated that there exists a likelihood of confusion between the figurative and word trademarks SKYPE and the prior word trademark SKY, which prevents the registration of the SKYPE […]

By |05 05 2015|Uncategorized|0 Comments|

The late submission of evidence in opposition proceedings against the registration of a trademark: a recent decision of the General Court of the European Union

By decision of 1 July 2014, the General Court of the European Union (“GCEU”) gave judgement regarding the late submission of evidence in opposition proceedings against the registration of a trademark. In this case, the opponent did not provide evidence of ownership of the earlier trademark within the prescribed […]

By |17 07 2014|Uncategorized|0 Comments|

General Court annuls the Commission’s decision refusing to grant a marketing authorisation for Orphacol

On 4 July the General Court of the European Union (“GC”) ruled in case T-301/12 as regards the grant of the Marketing Authorisation (“MA”) of Orphacol, a cholic acid-based orphan medicinal product which is used to treat two rare but very serious liver disorders (the “Medicinal Product”). Specifically, the […]

By |06 09 2013|Uncategorized|0 Comments|

2012 Report on EU Customs enforcement of IPRs published

(by Francesca Maculan)

The European Commission (“EC”) has recently published its report for the year 2012 on EU customs’ enforcement of intellectual property rights (“IPR”) in the European Union (“EU”). The report, published each year since 2000 based on data transmitted by the national customs administrations to the EC, gives […]

By |06 09 2013|Uncategorized|0 Comments|

EU General Court: EMA may not disclose clinical trials data

(by Francesca Maculan)

On 25 April, the President of the General Court of the European Union (“GC”) issued interim measures for suspension of operation of two decisions by the European Medicines Agency (“EMA”) granting third parties access to clinical trials data filed by pharmaceutical companies InterMune and AbbVie (jointly, the […]

By |27 06 2013|Uncategorized|0 Comments|